Munsat T L, Bradley W G
Neurology. 1977 Jan;27(1):96-7. doi: 10.1212/wnl.27.1.96.
Evidence is cited from the literature and from personal experience with the "inflammatory" form of facioscapulohumeral syndrome that the creatine phosphokinase reduction occurring during pharmacologic treatment of various neuromuscular diseases does not necessarily imply therapeutic benefit.
文献及本人对“炎症性”面肩肱型综合征的经验表明,在各种神经肌肉疾病的药物治疗过程中,肌酸磷酸激酶降低并不一定意味着治疗有效。